An article in the February 2010 issue of Journal of Medical Microbiology explores the potential of various bacteria strains to address the causes of Irritable Bowel Disease (IBD). Certain types of bacteria produce compounds that can reduce inflammation of the intestinal lining.

Nearly six months ago I wrote an article addressing the potential of bacteria within probiotics to address the issues associated with IBD. In that article I explained:

Here are the five top reasons to consider probiotics in individuals with IBD (3,5,6).

  • Probiotics adhere to the intestinal lining cells and competitively inhibit the harmful bacteria from taking up residence.
  • Probiotics suppress immune mediated inflammation by producing cytokines that inhibit the inflammatory process.
  • Probiotics produce antimicrobial products that inhibit the survival of harmful bacteria.
  • Probiotics enhance the intestinal lining cells health by tightening the junction between intestinal lining, thereby inhibiting the invasion by the harmful bacteria.
  • Probiotics have been shown to inhibit immune cells responses, which would result in further inflammation.

Researchers are now trying to identity which strains are the most effective for surviving within the intestinal tract of individuals with IBD, given their unique circumstances and depleted supply of functional bacteria.

To read more about this study, visit the Medical News Today article:
http://www.medicalnewstoday.com/articles/176550.php